Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nowak

Showing results (281-290 of 441) with videos related to

Pageof 45
Sort By:
Cancer Immunology, Immunotherapy : CII|December 5, 2008
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapyRobbert G van der Most, Andrew J Currie, Sathish Mahendran, et al.
Neuro-Oncology|April 26, 2015
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomideRobert W Rapkins, Fan Wang, HuyTram N Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cellsAnna K Nowak, Richard A Lake, Amanda L Marzo, et al.
Neuro-Oncology Practice|March 5, 2021
Exploring sleep disturbance among adults with primary or secondary malignant brain tumors and their caregiversMegan S Jeon, Haryana M Dhillon, Eng-Siew Koh, et al.
Physics in Medicine and Biology|September 17, 2025
Reinforcement learning with mechanistic models to optimise radiotherapy and immunotherapy combinations: a proof of conceptAllison M Ng, Du Q Huynh, Rebecca A D'Alonzo, et al.
Frontiers in Psychiatry|December 11, 2023
Neuro-ophthalmologic and blood biomarker responses in ADHD following subconcussive head impacts: a case-control trialMadeleine K Nowak, William G Kronenberger, Devin Rettke, et al.
Acta Biochimica Polonica|March 21, 2014
Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activityElzbieta Czub, Jan K Nowak, Anna Szaflarska-Poplawska, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trialK M Field, E H Barnes, H W Sim, et al.
Lung Cancer (Amsterdam, Netherlands)|January 18, 2022
Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest GroupSamuel G Armato, Anna K Nowak, Roslyn J Francis, et al.
British Journal of Cancer|December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancerM J McCoy, C Hemmings, T J Miller, et al.
Pageof 45

Showing results (281-290 of 441) with videos related to

Sort By:
Pageof 45
Cancer Immunology, Immunotherapy : CII|December 5, 2008
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapyRobbert G van der Most, Andrew J Currie, Sathish Mahendran, et al.
Neuro-Oncology|April 26, 2015
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomideRobert W Rapkins, Fan Wang, HuyTram N Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cellsAnna K Nowak, Richard A Lake, Amanda L Marzo, et al.
Neuro-Oncology Practice|March 5, 2021
Exploring sleep disturbance among adults with primary or secondary malignant brain tumors and their caregiversMegan S Jeon, Haryana M Dhillon, Eng-Siew Koh, et al.
Physics in Medicine and Biology|September 17, 2025
Reinforcement learning with mechanistic models to optimise radiotherapy and immunotherapy combinations: a proof of conceptAllison M Ng, Du Q Huynh, Rebecca A D'Alonzo, et al.
Frontiers in Psychiatry|December 11, 2023
Neuro-ophthalmologic and blood biomarker responses in ADHD following subconcussive head impacts: a case-control trialMadeleine K Nowak, William G Kronenberger, Devin Rettke, et al.
Acta Biochimica Polonica|March 21, 2014
Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activityElzbieta Czub, Jan K Nowak, Anna Szaflarska-Poplawska, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trialK M Field, E H Barnes, H W Sim, et al.
Lung Cancer (Amsterdam, Netherlands)|January 18, 2022
Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest GroupSamuel G Armato, Anna K Nowak, Roslyn J Francis, et al.
British Journal of Cancer|December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancerM J McCoy, C Hemmings, T J Miller, et al.
Pageof 45